MARKER THERAPEUTICS, INC. Increase (Decrease) in Derivative Liabilities
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Derivative Liabilities of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2022-03-17
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-06-30 was $0.00.
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2021-03-31 was $0.00.
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2020-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2020 was -$31.00K.
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2019 was -$18.00K, a 145.00% decline from fiscal 2018.
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2018 was $40.00K.
- MARKER THERAPEUTICS, INC. increase (decrease) in derivative liabilities for fiscal 2017 was -$5.50K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 3 month as first filed | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 6 month as first filed | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 9 month as first filed | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $0.00 10-Q · filed 2021-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | -$31.00K 10-K · filed 2022-03-17 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | -$31.00K 10-Q · filed 2021-11-10 | -$129.00K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$31.00K 10-Q · filed 2021-08-10 | -$129.00K derived: sum of 3 quarters · filed 2021-08-10 | -$65.00K derived: sum of 4 quarters · filed 2021-08-10 | |||
| 2020-03-31 | -$31.00K 10-Q · filed 2021-05-12 | -$129.00K derived: sum of 2 quarters · filed 2021-05-12 | -$65.00K derived: sum of 3 quarters · filed 2021-05-12 | -$58.00K derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$34.00K derived: sum of 2 quarters · filed 2021-03-09 | -$27.00K derived: sum of 3 quarters · filed 2021-03-09 | -$18.00K 10-K · filed 2021-03-09 | |||
| 2019-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $71.00K derived: sum of 2 quarters · filed 2020-11-09 | $80.00K 10-Q · filed 2020-11-09 | $22.00K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $16.00K 10-Q · filed 2020-08-10 | -$42.00K derived: sum of 3 quarters · filed 2020-08-10 | -$82.00K derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $9.00K 10-Q · filed 2020-05-11 | -$49.00K derived: sum of 2 quarters · filed 2020-05-11 | -$89.00K derived: sum of 3 quarters · filed 2020-05-11 | $50.00K derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$98.00K derived: sum of 2 quarters · filed 2020-03-12 | $41.00K derived: sum of 3 quarters · filed 2020-03-12 | $40.00K 10-K · filed 2020-03-12 | |||
| 2018-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $99.00K derived: sum of 2 quarters · filed 2019-11-12 | $98.00K 10-Q · filed 2019-11-12 | $101.00K derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $138.00K 10-Q · filed 2019-08-09 | $141.00K derived: sum of 3 quarters · filed 2019-08-09 | $137.00K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | -$1.00K 10-Q · filed 2019-05-10 | $2.00K derived: sum of 2 quarters · filed 2019-05-10 | -$2.00K derived: sum of 3 quarters · filed 2019-05-10 | -$9.50K derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$1.00K derived: sum of 2 quarters · filed 2019-03-15 | -$8.50K derived: sum of 3 quarters · filed 2019-03-15 | -$5.50K 10-K · filed 2019-03-15 | |||
| 2017-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$11.50K derived: sum of 2 quarters · filed 2018-11-13 | -$8.50K 10-Q · filed 2018-11-13 | -$23.00K derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | -$7.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$4.50K 10-Q · filed 2018-08-09 | -$19.00K derived: sum of 3 quarters · filed 2018-08-09 | -$703.00K derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $3.00K 10-Q · filed 2018-05-15 | -$11.50K derived: sum of 2 quarters · filed 2018-05-15 | -$695.50K derived: sum of 3 quarters · filed 2018-05-15 | -$8.93M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$14.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -$698.50K derived: sum of 2 quarters · filed 2018-03-23 | -$8.94M derived: sum of 3 quarters · filed 2018-03-23 | -$5.94M 10-K · filed 2018-03-23 | |||
| 2016-09-30 | -$684.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$8.92M derived: sum of 2 quarters · filed 2017-11-14 | -$5.92M 10-Q · filed 2017-11-14 | -$6.54M derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | -$8.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$5.24M 10-Q · filed 2017-08-07 | -$5.85M derived: sum of 3 quarters · filed 2017-08-07 | -$36.12M derived: sum of 4 quarters · filed 2017-08-07 | |||
| 2016-03-31 | $3.00M 10-Q · filed 2017-05-05 | $2.38M derived: sum of 2 quarters · filed 2017-05-05 | -$27.88M derived: sum of 3 quarters · filed 2017-05-05 | $31.20M derived: sum of 4 quarters · filed 2017-05-05 | |||
| 2015-12-31 | -$613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$30.88M derived: sum of 2 quarters · filed 2017-03-14 | $28.20M derived: sum of 3 quarters · filed 2017-03-14 | $27.87M 10-K · filed 2017-03-14 | |||
| 2015-09-30 | -$30.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $28.81M derived: sum of 2 quarters · filed 2016-11-04 | $28.49M 10-Q · filed 2016-11-04 | $4.76M 10-Q · filed 2015-11-16 | $28.73M derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-06-30 | $59.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $58.75M 10-Q · filed 2016-08-15 | $9.01M 10-Q · filed 2015-08-14 | $58.99M derived: sum of 3 quarters · filed 2016-08-15 | $58.77M derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | -$327.44K 10-Q · filed 2016-05-16 | -$46.44K 10-Q · filed 2015-05-15 | -$84.55K derived: sum of 2 quarters · filed 2016-05-16 | -$313.48K derived: sum of 3 quarters · filed 2016-05-16 | -$666.32K derived: sum of 4 quarters · filed 2016-05-16 | ||
| 2014-12-31 | $242.89K derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-04-14 | $13.96K derived: sum of 2 quarters · filed 2016-04-14 | -$338.88K derived: sum of 3 quarters · filed 2016-04-14 | -$581.00 10-K · filed 2016-04-14 | |||
| 2014-09-30 | -$228.94K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2016-04-14 | -$581.77K derived: sum of 2 quarters · filed 2016-04-14 | -$243.47K 10-Q/A · filed 2016-04-14 | ||||
| 2014-06-30 | -$352.83K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-04-14 | -$14.54K 10-Q/A · filed 2016-04-14 | |||||
| 2014-03-31 | $338.30K 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |